Latest Insider Transactions at Myomo, Inc. (MYO)
This section provides a real-time view of insider transactions for Myomo, Inc. (MYO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MYOMO, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MYOMO, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 20
2022
|
David A Henry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,297
+15.89%
|
-
|
|
May 20
2022
|
Harry Kovelman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,987
+20.59%
|
-
|
|
May 20
2022
|
Micah Mitchell Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,424
+24.18%
|
-
|
|
May 03
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-0.67%
|
$402
$3.03 P/Share
|
|
Apr 04
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-0.66%
|
$536
$4.01 P/Share
|
|
Mar 14
2022
|
Paul R Gudonis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+5.15%
|
$20,000
$4.22 P/Share
|
|
Mar 11
2022
|
Paul R Gudonis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+5.43%
|
$20,000
$4.63 P/Share
|
|
Mar 07
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
131
-0.64%
|
$917
$7.22 P/Share
|
|
Feb 03
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
132
-0.64%
|
$924
$7.6 P/Share
|
|
Jan 03
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-0.61%
|
$875
$7.22 P/Share
|
|
Dec 03
2021
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-0.62%
|
$896
$7.75 P/Share
|
|
Nov 16
2021
|
David A Henry Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+2.73%
|
$8,000
$8.86 P/Share
|
|
Nov 12
2021
|
Paul R Gudonis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+1.2%
|
$9,000
$9.86 P/Share
|
|
Nov 03
2021
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,625
-7.27%
|
$16,250
$10.39 P/Share
|
|
Nov 02
2021
|
Thomas Aloysius Crowley Jr. |
BUY
Exercise of conversion of derivative security
|
Direct |
419
+1.04%
|
$0
$0.05 P/Share
|
|
Jul 21
2021
|
Micah Mitchell Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,385
-8.03%
|
-
|
|
Jul 20
2021
|
Micah Mitchell Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,745
-25.0%
|
-
|
|
Jun 11
2021
|
Cliff Conneighton Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,083
-10.51%
|
-
|
|
Jun 11
2021
|
David A Henry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,548
-11.61%
|
-
|
|
Jun 11
2021
|
Micah Mitchell Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,133
-8.49%
|
-
|
|
Jun 10
2021
|
Thomas Aloysius Crowley Jr. |
BUY
Exercise of conversion of derivative security
|
Direct |
419
+2.05%
|
$0
$0.05 P/Share
|
|
Jun 10
2021
|
Cliff Conneighton Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
208
-1.04%
|
$2,288
$11.51 P/Share
|
|
Jun 10
2021
|
Micah Mitchell Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
154
-0.61%
|
$1,694
$11.51 P/Share
|
|
Jun 09
2021
|
Milton Mayo Morris |
BUY
Grant, award, or other acquisition
|
Direct |
2,945
+50.0%
|
-
|
|
Jun 09
2021
|
Paul R Gudonis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+19.8%
|
-
|
|
Jun 09
2021
|
Harry Kovelman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,100
+15.49%
|
-
|
|
Jun 09
2021
|
David A Henry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+20.34%
|
-
|
|
Jun 09
2021
|
Micah Mitchell Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,700
+18.41%
|
-
|
|
Jun 09
2021
|
Thomas Aloysius Crowley Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,945
+13.05%
|
-
|
|
Jun 09
2021
|
Thomas F Kirk |
BUY
Grant, award, or other acquisition
|
Direct |
2,945
+10.11%
|
-
|
|
Jun 09
2021
|
Amy K. Knapp |
BUY
Grant, award, or other acquisition
|
Direct |
2,945
+13.05%
|
-
|